Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) Vol. 179; no. 1; pp. 210 - 212
Main Authors: Curto‐Barredo, L., Spertino, J., Figueras‐Nart, I., Expósito‐Serrano, V., Guilabert, A., Melé‐Ninot, G., Cubiró, X., Bonfill‐Ortí, M., Garcias‐Ladaria, J., Villar, M., García‐Navarro, X., Bielsa‐Marsol, I., Vilavella, M., Aparicio, G., Baliu‐Piqué, C., Álvarez, A., Lamas‐Domenech, N., Duran‐Jordà, X., Serra‐Baldrich, E., Giménez‐Arnau, A.
Format: Journal Article
Language:English
Published: England 01-07-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ObjectType-Undefined-3
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.16379